isospaglumic acid has been researched along with Prostatic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkman, CE; Hosaka, M; Kamga, I; Ng, R | 1 |
| Brown, M; Chen, X; Huang, G; Shen, TY; Tang, H; Tenniswood, M; Wang, Y; Ye, Y; Zhai, H; Zhang, Y | 1 |
| Ghosh, A; Heston, WD | 1 |
| Carter, RE; Coyle, JT; Feldman, AR | 1 |
| Barczak, AK; Coyle, JT; Luthi-Carter, R; Speno, H | 1 |
| Jackson, PF; Lapidus, RG; Merion, A; Slusher, BS; Tiffany, CW | 1 |
| Isaacs, JT; Lapidus, RG; Slusher, BS; Tiffany, CW | 1 |
1 review(s) available for isospaglumic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
Topics: Alternative Splicing; Animals; Antigens, Surface; Contractile Proteins; Dipeptides; Endocytosis; Enhancer Elements, Genetic; Filamins; Folic Acid; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Humans; Male; Mice; Microfilament Proteins; Models, Biological; Prostatic Neoplasms; Receptors, Androgen | 2004 |
6 other study(ies) available for isospaglumic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
High-performance liquid chromatography method for detecting prostate-specific membrane antigen activity.
Topics: Antigens, Neoplasm; Antigens, Surface; Carboxypeptidases; Cell Membrane; Chromatography, High Pressure Liquid; Dipeptides; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Hydrolysis; Male; Prostatic Neoplasms; Tritium; Tumor Cells, Cultured | 2002 |
Prostate targeting ligands based on N-acetylated alpha-linked acidic dipeptidase.
Topics: Antigens, Neoplasm; Antigens, Surface; Carboxypeptidases; Cell Membrane; Cell Survival; Dipeptides; Enzyme Inhibitors; Fluorescent Dyes; Glutamate Carboxypeptidase II; Humans; Ligands; Male; Molecular Structure; Prostate; Prostatic Neoplasms; Protein Isoforms; Tumor Cells, Cultured | 2003 |
Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.
Topics: Animals; Antigens, Neoplasm; Antigens, Surface; Base Sequence; Cell Line; Dipeptidases; Dipeptides; DNA, Complementary; Gene Library; Glutamate Carboxypeptidase II; Humans; Immunoblotting; Male; Molecular Sequence Data; Neuropeptides; Prostatic Neoplasms; Rats; Receptors, Glutamate; Sequence Analysis, DNA; Signal Transduction | 1996 |
Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
Topics: Animals; Antigens, Surface; Binding, Competitive; Carboxypeptidases; Chelating Agents; Cloning, Molecular; Cobalt; Coumarins; Dipeptides; Edetic Acid; Folic Acid; Glutamate Carboxypeptidase II; Histamine H1 Antagonists; Humans; Hydrolysis; Isocoumarins; Kinetics; Leucine; Male; Neuropeptides; Pepstatins; Phenanthrolines; Prostatic Neoplasms; Protease Inhibitors; Rats; Serine Proteinase Inhibitors; Substrate Specificity; Synaptic Transmission; Tumor Cells, Cultured | 1998 |
Suramin potently inhibits the enzymatic activity of PSM.
Topics: Antigens, Surface; Antineoplastic Agents; Carboxypeptidases; Chromatography, Ion Exchange; Dipeptides; Dose-Response Relationship, Drug; Glutamate Carboxypeptidase II; Humans; Male; Phosphates; Prostatic Neoplasms; Quisqualic Acid; Scintillation Counting; Suramin; Tumor Cells, Cultured | 2000 |
Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells.
Topics: Antigens, Surface; Carboxypeptidases; Cell Membrane; Cytosol; Dipeptides; Glutamate Carboxypeptidase II; Humans; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms | 2000 |